Question 1

What is Cencora's P/B ratio?

Accepted Answer

Cencora (COR) P/B ratio is 15.8× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by book value of equity, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/B ratio calculated?

Accepted Answer

P/B = Market Capitalisation ÷ Book Value of Equity (most recent quarterly shareholders' equity), or equivalently Share Price ÷ Book Value Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/B ratio?

Accepted Answer

The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.

Question 4

What is a good P/B ratio for Cencora?

Accepted Answer

A "good" P/B depends on the business model. Banks, insurers, and other capital-heavy financials typically trade near 1×; asset-light technology and consumer-brand companies can sustainably trade at 5×+ because much of their value is intangible. P/B is most informative when paired with return on equity (ROE). For Cencora specifically, the relevant sector benchmark is the current sector median of 3.4×.

Question 5

Is Cencora's P/B ratio high or low?

Accepted Answer

Cencora's P/B ratio of 15.8× is below its own 5-year average of 103.0× and above the sector median of 3.4×. That places the current reading at the 2th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Cencora's historical P/B ratio range?

Accepted Answer

In the available daily series, Cencora (COR) P/B ratio has ranged from a low of 1.4× in 2004 to a high of 692.3× in 2021. The 5-year average is 103.0× and the 5-year median is 57.8×.

Question 7

What was Cencora's P/B ratio in 2025?

Accepted Answer

Cencora (COR) P/B ratio at the end of 2025 was 40.2×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month book value figure available at that date.

Question 8

Why does Cencora's P/B ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (book value). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$60.60B	$1.51B	40.2×	-29.0×	Sep 30, 2025
2024	$44.68B	$645.94M	69.2×	-1.0×	Sep 30, 2024
2023	$36.60B	$522.00M	70.1×	—	Sep 30, 2023
2022	$28.04B	−$211.56M	—	—	Sep 30, 2022
2021	$24.83B	$223.35M	111.2×	—	Sep 30, 2021
2020	$19.78B	−$1.02B	—	—	Sep 30, 2020
2019	$17.12B	$2.88B	5.9×	-0.9×	Sep 30, 2019
2018	$19.99B	$2.93B	6.8×	-1.9×	Sep 30, 2018
2017	$18.08B	$2.06B	8.8×	+0.4×	Sep 30, 2017
2016	$17.70B	$2.13B	8.3×	-23.5×	Sep 30, 2016
2015	$20.15B	$633.52M	31.8×	+23.0×	Sep 30, 2015
2014	$17.32B	$1.96B	8.9×	+2.8×	Sep 30, 2014
2013	$14.08B	$2.32B	6.1×	+2.2×	Sep 30, 2013
2012	$9.47B	$2.46B	3.9×	+0.4×	Sep 30, 2012
2011	$9.93B	$2.87B	3.5×	+0.6×	Sep 30, 2011
2010	$8.55B	$2.95B	2.9×	+0.5×	Sep 30, 2010
2009	$6.55B	$2.72B	2.4×	+0.2×	Sep 30, 2009
2008	$5.89B	$2.71B	2.2×	-0.4×	Sep 30, 2008
2007	$7.83B	$3.10B	2.5×	+0.4×	Sep 30, 2007
2006	$8.99B	$4.14B	2.2×	+0.2×	Sep 30, 2006
2005	$8.22B	$4.28B	1.9×	+0.5×	Sep 30, 2005
2004	$6.01B	$4.34B	1.4×	-0.1×	Sep 30, 2004
2003	$5.88B	$4.01B	1.5×	-0.8×	Sep 30, 2003
2002	$7.59B	$3.32B	2.3×	—	Sep 30, 2002


Quest Diagnostics (DGX)	2.9×
Moderna (MRNA)	2.7×
Charles River (CRL)	2.6×
Regeneron Pharmaceuticals (REGN)	2.6×
Henry Schein (HSIC)	2.5×
Labcorp Holdings (LH)	2.5×
Danaher (DHR)	2.4×
UnitedHealth Group (UNH)	2.4×
Solventum (SOLV)	2.3×
Becton, Dickinson and (BDX)	1.8×
Pfizer (PFE)	1.8×
Molina Healthcare (MOH)	1.7×
Cigna (CI)	1.7×
Waters Corporation (WAT)	1.6×
Cooper Companies (COO)	1.5×
Elevance Health (ELV)	1.5×
Universal Health Services (UHS)	1.5×
Biogen (BIIB)	1.4×
Baxter International (BAX)	1.4×
Revvity (RVTY)	1.4×
Zimmer Biomet Holdings (ZBH)	1.2×
CVS Health (CVS)	1.2×
Humana (HUM)	1.1×
Viatris (VTRS)	1.1×
Centene (CNC)	0.8×

P/B Ratio for Cencora (COR)

P/B Ratio daily chart for Cencora (COR)

Historical P/B Ratio for Cencora (COR) from 2002 to 2025

About P/B Ratio at Cencora (COR)

Cencora P/B Ratio by Year

Cencora P/B Ratio 2025: 40.2×

Cencora P/B Ratio 2024: 69.2×

Cencora P/B Ratio 2023: 70.1×

Cencora P/B Ratio 2021: 111.2×

Cencora P/B Ratio 2019: 5.9×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

Cencora (COR) Key Financials

P/B Ratio daily chart for Cencora (COR)

Historical P/B Ratio for Cencora (COR) from 2002 to 2025

About P/B Ratio at Cencora (COR)

Cencora P/B Ratio by Year

Cencora P/B Ratio 2025: 40.2×

Cencora P/B Ratio 2024: 69.2×

Cencora P/B Ratio 2023: 70.1×

Cencora P/B Ratio 2021: 111.2×

Cencora P/B Ratio 2019: 5.9×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

+What is Cencora's P/B ratio?

+How is the P/B ratio calculated?

+What is the P/B ratio?

+What is a good P/B ratio for Cencora?

+Is Cencora's P/B ratio high or low?

+What is Cencora's historical P/B ratio range?

+What was Cencora's P/B ratio in 2025?

+Why does Cencora's P/B ratio change over time?

Cencora (COR) Key Financials